Opus Point Partners Management, LLC historic quarter change: USA Stocks, Added
In share positions in stocks (listed in the US), over 7 quarters from 2014-12-31 to 2016-09-30, Opus Point Partners Management, LLC opened 19 positions, added to 60, reduced 54 and sold out of 17.
- Q3 2016: Stock BMY; Country of operation United States; Class COM; Shares before 71,703.
- Q3 2016: Stock BIIB; Country of operation United States; Class COM; Shares before 9,042.
- Q3 2016: Stock IONS; Country of operation United States; Class COM; Shares before 70,868.
- Q3 2016: Stock AGIO; Country of operation United States; Class COM; Shares before 43,295.
Each consecutive pair of Form 13F-HR filings compared (SEC CIK 1600175), 7 quarters: Q3 2016 (2016-06-30 to 2016-09-30, filed 2016-11-14); Q2 2016 (2016-03-31 to 2016-06-30, filed 2016-08-15); Q1 2016 (2015-12-31 to 2016-03-31, filed 2016-05-16); Q4 2015 (2015-09-30 to 2015-12-31, filed 2016-02-16); Q3 2015 (2015-06-30 to 2015-09-30, filed 2015-11-16); Q2 2015 (2015-03-31 to 2015-06-30, filed 2015-08-14); Q1 2015 (2014-12-31 to 2015-03-31, filed 2015-05-18). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move. Only the filings held here are compared; the firm's 13F-HR filings go back to the quarter ended 2014-12-31.
| Quarter | Stock | Country of operation | Class | Shares before | Shares after | Share change | Value before | Value after | Value change | Filed |
|---|
| Q3 2016 | BMY
BRISTOL MYERS SQUIBB CO | United States | COM | 71,703 | 75,686 | +3,983 | $5,274,000 | $4,081,000 | -$1,193,000 | 2016-11-14 |
|---|
| Q3 2016 | BIIB
BIOGEN INC | United States | COM | 9,042 | 10,704 | +1,662 | $2,187,000 | $3,351,000 | +$1,164,000 | 2016-11-14 |
|---|
| Q3 2016 | IONS
IONIS PHARMACEUTICALS INC | United States | COM | 70,868 | 76,439 | +5,571 | $1,651,000 | $2,801,000 | +$1,150,000 | 2016-11-14 |
|---|
| Q3 2016 | AGIO
AGIOS PHARMACEUTICALS INC | United States | COM | 43,295 | 54,692 | +11,397 | $1,814,000 | $2,889,000 | +$1,075,000 | 2016-11-14 |
|---|
| Q3 2016 | ALNY
ALNYLAM PHARMACEUTICALS INC | United States | COM | 43,684 | 45,064 | +1,380 | $2,424,000 | $3,054,000 | +$630,000 | 2016-11-14 |
|---|
| Q3 2016 | BMRN
BIOMARIN PHARMACEUTICAL INC | United States | COM | 28,915 | 30,639 | +1,724 | $2,250,000 | $2,835,000 | +$585,000 | 2016-11-14 |
|---|
| Q3 2016 | REGN
REGENERON PHARMACEUTICALS | United States | COM | 7,233 | 7,512 | +279 | $2,526,000 | $3,020,000 | +$494,000 | 2016-11-14 |
|---|
| Q3 2016 | VRTX
VERTEX PHARMACEUTICALS INC | United States | COM | 30,248 | 32,141 | +1,893 | $2,602,000 | $2,803,000 | +$201,000 | 2016-11-14 |
|---|
| Q2 2016 | PFE
PFIZER INC | United States | COM | 110,000 | 112,300 | +2,300 | $3,260,000 | $3,954,000 | +$694,000 | 2016-08-15 |
|---|
| Q1 2016 | ALKS
ALKERMES PLC | | SHS | 87,415 | 102,277 | +14,862 | $6,939,000 | $3,497,000 | -$3,442,000 | 2016-05-16 |
|---|
| Q1 2016 | INCY
INCYTE CORP | United States | COM | 48,045 | 51,677 | +3,632 | $5,210,000 | $3,745,000 | -$1,465,000 | 2016-05-16 |
|---|
| Q1 2016 | BMRN
BIOMARIN PHARMACEUTICAL INC | United States | COM | 43,870 | 48,260 | +4,390 | $4,596,000 | $3,980,000 | -$616,000 | 2016-05-16 |
|---|
| Q1 2016 | PCRX
PACIRA PHARMACEUTICALS INC | United States | COM | 19,110 | 35,110 | +16,000 | $1,467,000 | $1,860,000 | +$393,000 | 2016-05-16 |
|---|
| Q1 2016 | BIIB
BIOGEN INC | United States | COM | 10,482 | 11,125 | +643 | $3,211,000 | $2,896,000 | -$315,000 | 2016-05-16 |
|---|
| Q1 2016 | ALNY
ALNYLAM PHARMACEUTICALS INC | United States | COM | 50,222 | 77,593 | +27,371 | $4,728,000 | $4,871,000 | +$143,000 | 2016-05-16 |
|---|
| Q1 2016 | AGIO
AGIOS PHARMACEUTICALS INC | United States | COM | 34,000 | 51,000 | +17,000 | $2,207,000 | $2,071,000 | -$136,000 | 2016-05-16 |
|---|
| Q4 2015 | AMGN
AMGEN INC | United States | COM | 5,626 | 35,773 | +30,147 | $778,000 | $5,807,000 | +$5,029,000 | 2016-02-16 |
|---|
| Q4 2015 | BMY
BRISTOL MYERS SQUIBB CO | United States | COM | 36,000 | 77,100 | +41,100 | $2,131,000 | $5,304,000 | +$3,173,000 | 2016-02-16 |
|---|
| Q4 2015 | GILD
GILEAD SCIENCES INC | United States | COM | 4,323 | 33,700 | +29,377 | $424,000 | $3,410,000 | +$2,986,000 | 2016-02-16 |
|---|
| Q4 2015 | MRK
MERCK & CO INC NEW | United States | COM | 41,000 | 90,000 | +49,000 | $2,025,000 | $4,754,000 | +$2,729,000 | 2016-02-16 |
|---|
| Q4 2015 | ALKS
ALKERMES PLC | | SHS | 86,864 | 87,415 | +551 | $5,096,000 | $6,939,000 | +$1,843,000 | 2016-02-16 |
|---|
| Q4 2015 | VRTX
VERTEX PHARMACEUTICALS INC | United States | COM | 40,876 | 41,662 | +786 | $4,257,000 | $5,242,000 | +$985,000 | 2016-02-16 |
|---|
| Q4 2015 | REGN
REGENERON PHARMACEUTICALS | United States | COM | 10,627 | 10,714 | +87 | $4,943,000 | $5,816,000 | +$873,000 | 2016-02-16 |
|---|
| Q4 2015 | ALNY
ALNYLAM PHARMACEUTICALS INC | United States | COM | 48,448 | 50,222 | +1,774 | $3,893,000 | $4,728,000 | +$835,000 | 2016-02-16 |
|---|
| Q4 2015 | LAB
FLUIDIGM CORP DEL | United States | COM | 15,000 | 70,000 | +55,000 | $122,000 | $757,000 | +$635,000 | 2016-02-16 |
|---|
| Q4 2015 | UTHR
UNITED THERAPEUTICS CORP DEL | United States | COM | 5,571 | 6,514 | +943 | $731,000 | $1,020,000 | +$289,000 | 2016-02-16 |
|---|
| Q4 2015 | BMRN
BIOMARIN PHARMACEUTICAL INC | United States | COM | 42,012 | 43,870 | +1,858 | $4,425,000 | $4,596,000 | +$171,000 | 2016-02-16 |
|---|
| Q4 2015 | INCY
INCYTE CORP | United States | COM | 47,400 | 48,045 | +645 | $5,230,000 | $5,210,000 | -$20,000 | 2016-02-16 |
|---|
| Q3 2015 | TECH
BIO TECHNE CORP | United States | COM | 34,000 | 47,000 | +13,000 | $3,348,000 | $4,346,000 | +$998,000 | 2015-11-16 |
|---|
| Q3 2015 | INCY
INCYTE CORP | United States | COM | 41,873 | 47,400 | +5,527 | $4,364,000 | $5,230,000 | +$866,000 | 2015-11-16 |
|---|
| Q3 2015 | MTD
METTLER TOLEDO INTERNATIONAL | | COM | 11,000 | 15,200 | +4,200 | $3,756,000 | $4,328,000 | +$572,000 | 2015-11-16 |
|---|
| Q3 2015 | BIIB
BIOGEN INC | United States | COM | 11,254 | 17,467 | +6,213 | $4,546,000 | $5,097,000 | +$551,000 | 2015-11-16 |
|---|
| Q3 2015 | BMRN
BIOMARIN PHARMACEUTICAL INC | United States | COM | 35,899 | 42,012 | +6,113 | $4,910,000 | $4,425,000 | -$485,000 | 2015-11-16 |
|---|
| Q3 2015 | REGN
REGENERON PHARMACEUTICALS | United States | COM | 8,759 | 10,627 | +1,868 | $4,468,000 | $4,943,000 | +$475,000 | 2015-11-16 |
|---|
| Q3 2015 | ALNY
ALNYLAM PHARMACEUTICALS INC | United States | COM | 34,979 | 48,448 | +13,469 | $4,193,000 | $3,893,000 | -$300,000 | 2015-11-16 |
|---|
| Q3 2015 | ILMN
ILLUMINA INC | United States | COM | 21,451 | 28,334 | +6,883 | $4,684,000 | $4,982,000 | +$298,000 | 2015-11-16 |
|---|
| Q3 2015 | UTHR
UNITED THERAPEUTICS CORP DEL | United States | COM | 5,399 | 5,571 | +172 | $939,000 | $731,000 | -$208,000 | 2015-11-16 |
|---|
| Q3 2015 | VRTX
VERTEX PHARMACEUTICALS INC | United States | COM | 35,276 | 40,876 | +5,600 | $4,356,000 | $4,257,000 | -$99,000 | 2015-11-16 |
|---|
| Q3 2015 | AMGN
AMGEN INC | United States | COM | 5,550 | 5,626 | +76 | $852,000 | $778,000 | -$74,000 | 2015-11-16 |
|---|
| Q3 2015 | GILD
GILEAD SCIENCES INC | United States | COM | 4,234 | 4,323 | +89 | $496,000 | $424,000 | -$72,000 | 2015-11-16 |
|---|
| Q2 2015 | ILMN
ILLUMINA, INC. CMN | United States | COM | 20,609 | 21,451 | +842 | $3,826,000 | $4,684,000 | +$858,000 | 2015-08-14 |
|---|
| Q2 2015 | BMRN
BIOMARIN PHARMACEUTICAL INC CMN | United States | COM | 32,545 | 35,899 | +3,354 | $4,056,000 | $4,910,000 | +$854,000 | 2015-08-14 |
|---|
| Q2 2015 | ALKS
ALKERMES PLC CMN | | COM | 62,546 | 71,022 | +8,476 | $3,813,000 | $4,570,000 | +$757,000 | 2015-08-14 |
|---|
| Q2 2015 | MTD
METTLER-TOLEDO INTL CMN | | COM | 9,436 | 11,000 | +1,564 | $3,101,000 | $3,756,000 | +$655,000 | 2015-08-14 |
|---|
| Q2 2015 | BIIB
BIOGEN INC. CMN | United States | COM | 9,331 | 11,254 | +1,923 | $3,940,000 | $4,546,000 | +$606,000 | 2015-08-14 |
|---|
| Q2 2015 | REGN
REGENERON PHARMACEUTICAL INC CMN | United States | COM | 8,750 | 8,759 | +9 | $3,950,000 | $4,468,000 | +$518,000 | 2015-08-14 |
|---|
| Q2 2015 | VRTX
VERTEX PHARMACEUTICALS INC CMN | United States | COM | 32,805 | 35,276 | +2,471 | $3,870,000 | $4,356,000 | +$486,000 | 2015-08-14 |
|---|
| Q2 2015 | TECH
BIO TECHNE CORP CMN | United States | COM | 30,917 | 34,000 | +3,083 | $3,101,000 | $3,348,000 | +$247,000 | 2015-08-14 |
|---|
| Q2 2015 | PCRX
PACIRA PHARMACEUTICALS, INC. CMN | United States | COM | 34,949 | 47,000 | +12,051 | $3,105,000 | $3,324,000 | +$219,000 | 2015-08-14 |
|---|
| Q2 2015 | GILD
GILEAD SCIENCES CMN | United States | COM | 3,651 | 4,234 | +583 | $358,000 | $496,000 | +$138,000 | 2015-08-14 |
|---|
| Q2 2015 | AMGN
AMGEN INC. CMN | United States | COM | 4,938 | 5,550 | +612 | $789,000 | $852,000 | +$63,000 | 2015-08-14 |
|---|
| Q2 2015 | UTHR
UNITED THERAPEUTICS CORP CMN | United States | COM | 5,213 | 5,399 | +186 | $899,000 | $939,000 | +$40,000 | 2015-08-14 |
|---|
| Q1 2015 | ALKS
ALKERMES PLC CMN | | COM | 19,631 | 62,546 | +42,915 | $1,150,000 | $3,813,000 | +$2,663,000 | 2015-05-18 |
|---|
| Q1 2015 | ALNY
ALNYLAM PHARMACEUTICALS, INC. CMN | United States | COM | 17,875 | 37,388 | +19,513 | $1,734,000 | $3,904,000 | +$2,170,000 | 2015-05-18 |
|---|
| Q1 2015 | TECH
BIO TECHNE CORP CMN | United States | COM | 27,900 | 30,917 | +3,017 | $2,578,000 | $3,101,000 | +$523,000 | 2015-05-18 |
|---|
| Q1 2015 | VCEL
VERICEL CORP CMN | United States | COM | 283,270 | 362,157 | +78,887 | $861,000 | $1,340,000 | +$479,000 | 2015-05-18 |
|---|
| Q1 2015 | ILMN
ILLUMINA, INC. CMN | United States | COM | 18,394 | 20,609 | +2,215 | $3,395,000 | $3,826,000 | +$431,000 | 2015-05-18 |
|---|
| Q1 2015 | VRTX
VERTEX PHARMACEUTICALS INC CMN | United States | COM | 29,096 | 32,805 | +3,709 | $3,457,000 | $3,870,000 | +$413,000 | 2015-05-18 |
|---|
| Q1 2015 | REGN
REGENERON PHARMACEUTICAL INC CMN | United States | COM | 8,650 | 8,750 | +100 | $3,549,000 | $3,950,000 | +$401,000 | 2015-05-18 |
|---|
| Q1 2015 | AGIO
AGIOS PHARMACEUTICALS, INC. CMN | United States | COM | 4,416 | 5,000 | +584 | $495,000 | $472,000 | -$23,000 | 2015-05-18 |
|---|
Similar Firms
| Firm Name | Country | 13F Value | Holdings |
|---|
| Not available yet |